149 related articles for article (PubMed ID: 3896861)
1. An estrogen test to determine the times of potential fertility in women.
Schiphorst LE; Collins WP; Royston JP
Fertil Steril; 1985 Sep; 44(3):328-34. PubMed ID: 3896861
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of the BIOSELF 110 fertility indicator.
Ismail M; Arshat H; Pulcrano J; Royston P; Spieler J
Contraception; 1989 Jan; 39(1):53-71. PubMed ID: 2642781
[TBL] [Abstract][Full Text] [Related]
3. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
[TBL] [Abstract][Full Text] [Related]
4. A prospective multicentre study to develop universal immunochemical tests for predicting the fertile period in women. World Health Organisation Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
Int J Fertil; 1985; 30(3):18-30. PubMed ID: 2867054
[TBL] [Abstract][Full Text] [Related]
5. Ovulation prediction: changes in the concentrations of urinary estrone-3-glucuronide, estradiol-17 beta-glucuronide and estriol-16 alpha-glucuronide during conceptional cycles.
Branch CM; Collins PO; Collins WP
J Steroid Biochem; 1982 Feb; 16(2):345-7. PubMed ID: 7078170
[TBL] [Abstract][Full Text] [Related]
6. Symptothermal and hormonal markers of potential fertility in climacteric women.
Flynn AM; James P; Collins WP; Royston P
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):1987-9. PubMed ID: 1755454
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between indicators of the fertile period of the menstrual cycle and ultrasonically-determined ovulation].
Croce P; Quarenghi A; Montanari G; Barbato M; Pravettoni G; Bertolotti G
Minerva Endocrinol; 1989; 14(3):147-52. PubMed ID: 2622425
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ovulation by low-dose mifepristone (RU 486).
Ledger WL; Sweeting VM; Hillier H; Baird DT
Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
[TBL] [Abstract][Full Text] [Related]
9. A prototype for ovulation detection: pros and cons.
Lasley BL; Shideler SE; Munro CJ
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2003-7. PubMed ID: 1755459
[TBL] [Abstract][Full Text] [Related]
10. The measurement of urinary steroid glucuronides as indices of the fertile period in women. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, special programme of research, development and research training in human reproduction.
Adlercreutz H; Brown J; Collins W; Goebelsman U; Kellie A; Campbell H; Spieler J; Braissand G
J Steroid Biochem; 1982 Dec; 17(6):695-702. PubMed ID: 7176659
[TBL] [Abstract][Full Text] [Related]
11. Temporal relationships between indices of the fertile period.
Fertil Steril; 1983 May; 39(5):647-55. PubMed ID: 6840308
[TBL] [Abstract][Full Text] [Related]
12. Identifying the fertile phase of the human menstrual cycle.
Royston P
Stat Med; 1991 Feb; 10(2):221-40. PubMed ID: 2052801
[TBL] [Abstract][Full Text] [Related]
13. Use of the Home Ovarian Monitor in pregnancy avoidance.
Brown JB; Holmes J; Barker G
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2008-11. PubMed ID: 1755460
[TBL] [Abstract][Full Text] [Related]
14. Personal hormone monitoring for contraception.
Bonnar J; Flynn A; Freundl G; Kirkman R; Royston R; Snowden R
Br J Fam Plann; 1999 Jan; 24(4):128-34. PubMed ID: 10023097
[TBL] [Abstract][Full Text] [Related]
15. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.
Stanczyk FZ; Miyakawa I; Goebelsmann U
Am J Obstet Gynecol; 1980 Jun; 137(4):443-50. PubMed ID: 7386528
[TBL] [Abstract][Full Text] [Related]
16. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
[TBL] [Abstract][Full Text] [Related]
17. Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements.
Behre HM; Kuhlage J; Gassner C; Sonntag B; Schem C; Schneider HP; Nieschlag E
Hum Reprod; 2000 Dec; 15(12):2478-82. PubMed ID: 11098014
[TBL] [Abstract][Full Text] [Related]
18. Correlation of ovarian follicle size and the urinary excretion of oestrone glucuronide, luteinizing hormone and pregnanediol glucuronide in spontaneous cycles.
Adekunle AO; Collins WP; Whitehead MI
Afr J Med Med Sci; 1988 Jun; 17(2):77-82. PubMed ID: 2843021
[TBL] [Abstract][Full Text] [Related]
19. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
20. A possible method for the detection of ovulation and the determination of the duration of the fertile period.
Baker TS; Jennison K; Kellie AE
J Steroid Biochem; 1980 Jan; 12():411-5. PubMed ID: 7421226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
